Biotech News
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
investor.si-bone.com2026-05-06 14:55 EST
Fiscal Year 2025 worldwide revenue of $200.8 to $200.9 million, representing growth of ~20% SANTA CLARA, Calif. , Jan. 12, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone,